Clear-cell Renal Cell Carcinoma: Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors

A Verbiest , I Renders , S Caruso , G Couchy , S Job , A Laenen , V Verkarre , N Rioux-Leclercq (1) , P Schöffski , Y Vano , Rt Elaidi , E Lerut , M Albersen , S Oudard , Wh Fridman , C Sautès-Fridman , L Albigès , A Wozniak , J Zucman-Rossi , B. Beuselinck

1 Irset - Institut de recherche en santé, environnement et travail

Mots clés: Angiogenesis; Biomarker; Immune checkpoint inhibitor; Molecular subtype; Sunitinib

Domaines: Cancer

A Verbiest, I Renders, S Caruso, G Couchy, S Job, et al.. Clear-cell Renal Cell Carcinoma: Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors. Clinical Genitourinary Cancer, 2019, 17 (5), pp.e981-e994. ⟨10.1016/j.clgc.2019.05.009⟩. ⟨hal-02454456⟩